SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-24-016840
Filing Date
2024-04-29
Accepted
2024-04-29 07:30:12
Documents
3
Period of Report
2024-04-29

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 431283
2 proxy_001.jpg GRAPHIC 178610
3 proxy_002.jpg GRAPHIC 178739
  Complete submission text file 0001493152-24-016840.txt   924801
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

IRS No.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39318 | Film No.: 24886599
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)